These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8740976)

  • 1. Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.
    Schnierle P; Hering F; Seiler H
    Urol Res; 1996; 24(2):79-82. PubMed ID: 8740976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.
    Schnierle P
    Experientia; 1995 Nov; 51(11):1068-72. PubMed ID: 7498447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoelectric focusing of native urinary uromodulin (Tamm-Horsfall protein) shows no physicochemical differences between stone formers and non-stone formers.
    Trewick AL; Rumsby G
    Urol Res; 1999 Aug; 27(4):250-4. PubMed ID: 10460894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile.
    Jefferson A; Reynolds TM; Elves A; Wierzbicki AS
    Ann Clin Biochem; 1996 Nov; 33 ( Pt 6)():540-4. PubMed ID: 8937586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy.
    Knörle R; Schnierle P; Koch A; Buchholz NP; Hering F; Seiler H; Ackermann T; Rutishauser G
    Clin Chem; 1994 Sep; 40(9):1739-43. PubMed ID: 8070085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological detection of nitrosative stress-mediated modified Tamm-Horsfall glycoprotein (THP) in calcium oxalate stone formers.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Anandkumar P; Varalakshmi P
    Biomarkers; 2006; 11(2):153-63. PubMed ID: 16766391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.
    Erwin DT; Kok DJ; Alam J; Vaughn J; Coker O; Carriere BT; Lindberg J; Husserl FE; Fuselier H; Cole FE
    Am J Kidney Dis; 1994 Dec; 24(6):893-900. PubMed ID: 7985666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on macromolecular precipitation inhibitors of calcium oxalate.
    Schnierle P; Sialm F; Seiler HG; Hering F; Rutishauser G
    Urol Res; 1992; 20(1):7-11. PubMed ID: 1736490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamm Horsfall mucoprotein in urine of potential bladder stone formers.
    Sophasan S; Chatasingh S; Thanphaichitr P; Dhanamitta S
    J Urol; 1980 Oct; 124(4):522-4. PubMed ID: 6775093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI).
    Lopez M; Nakagawa Y; Coe FL; Tsai C; Michael AF; Scheinman JI
    Kidney Int; 1986 Apr; 29(4):829-33. PubMed ID: 3520093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of Tamm-Horsfall glycoprotein in calcium oxalate crystallisation.
    Yoshioka T; Koide T; Utsunomiya M; Itatani H; Oka T; Sonoda T
    Br J Urol; 1989 Nov; 64(5):463-7. PubMed ID: 2611614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the presence of abnormal proteins in the urine of recurrent stone formers.
    Grover PK; Resnick MI
    J Urol; 1995 May; 153(5):1716-21. PubMed ID: 7715017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.